Treatment strategies and issues in low/intermediate-1-risk myelodysplastic syndrome (MDS) patients

被引：7

作者：

Bowen, DT ^{[1
]}

机构：

[1] Univ Dundee, Dept Mol & Cellular Pathol, Dundee DD1 4HN, Scotland

来源：

SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 04期

关键词：

D O I：

10.1053/j.seminoncol.2005.06.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S16 / S23

页数：8

共 38 条

[1]

Aguayo Alvaro, 2004, Curr Hematol Rep, V3, P184

[2] Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].

Bartlett, JB ;

Dredge, K ;

Dalgleish, AG .

NATURE REVIEWS CANCER, 2004, 4 (04) :314-322

[3] Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J].

Bellamy, WT ;

Richter, L ;

Sirjani, D ;

Roxas, C ;

Glinsmann-Gibson, B ;

Frutiger, Y ;

Grogan, TM ;

List, AF .

BLOOD, 2001, 97 (05) :1427-1434

[4] Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes [J].

Bowen, D ;

Culligan, D ;

Jowitt, S ;

Kelsey, S ;

Mufti, G ;

Oscier, D ;

Parker, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :187-200

[5] Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes:: a randomized, controlled trial [J].

Casadevall, N ;

Durieux, P ;

Dubois, S ;

Hemery, F ;

Lepage, E ;

Quarré, MC ;

Damaj, G ;

Giraudier, S ;

Guerci, A ;

Laurent, G ;

Dombret, H ;

Chomienne, C ;

Ribrag, V ;

Stamatoullas, A ;

Marie, JP ;

Vekhoff, A ;

Maloisel, F ;

Navarro, R ;

Dreyfus, F ;

Fenaux, P .

BLOOD, 2004, 104 (02) :321-327

[6]

Cazzola M, 1998, HAEMATOLOGICA, V83, P910

[7]

Cheson BD, 2000, BLOOD, V96, P3671

[8] Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly [J].

Cheung, W ;

Minton, N ;

Gunawardena, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (05) :411-418

[9]

Dougherty FC, 2003, BLOOD, V102, p204A

[10] Myelodysplastic syndromes: From pathogenesis and prognosis to treatment [J].

Fenaux, P .

SEMINARS IN HEMATOLOGY, 2004, 41 (02) :6-12

← 1 2 3 4 →